体重指数对性别肯定阴道成形术手术结局的影响:回顾性队列分析
该单中心回顾性队列纳入2016至2023年766例初次性别肯定阴道成形术患者,按BMI分为偏瘦、正常、超重和肥胖四组。肥胖组估计失血量显著更高,术后尿路感染率在偏瘦组(14.8%)和肥胖组(10.7%)最高,手术部位感染主要见于偏瘦患者(3.7%);功能结局在各BMI组间一致良好。结论认为BMI影响围手术期并发症,但不应成为手术禁忌。
要点
- 肥胖组估计失血量显著更高,需关注围手术期出血风险。
- 术后尿路感染率随BMI不同而有差异,偏瘦组(14.8%)与肥胖组(10.7%)最高。
- 偏瘦患者手术部位感染(3.7%)和需再手术的部分移植物失败更常见。
核心结论
- BMI影响性别肯定阴道成形术的围手术期并发症,但不应因此排除患者接受该手术。
研究设计与样本
- 单中心回顾性队列研究,纳入2016至2023年766例初次性别肯定阴道成形术患者。
- 暴露为BMI分组:偏瘦(<18.5 kg/m²)、正常(18.5-24.9 kg/m²)、超重(25-29.9 kg/m²)、肥胖(≥30 kg/m²)。
- 连续变量用Kruskal-Wallis检验,分类结局用卡方或Fisher精确检验,P<.05为显著,使用R 4.5.1分析。
主要发现
- 肥胖组估计失血量显著更高(P<.05)。
- 术后尿路感染率随BMI不同而有差异(P=.02),偏瘦组14.8%、肥胖组10.7%最高。
- 手术部位感染随BMI不同而有差异(P=.05),主要见于偏瘦患者(3.7%)。
- 需再手术的部分移植物失败在较低BMI组更常见(P=.04)。
- 其他并发症组间无显著差异;触觉 sensation(≥98%)、外观满意度(>97%)、插入式性交能力(20%-40%)在各BMI组一致(P>.05)。
关键数值与推荐
- BMI分组界值:偏瘦<18.5 kg/m²、正常18.5-24.9 kg/m²、超重25-29.9 kg/m²、肥胖≥30 kg/m²。
- 术后尿路感染率差异P=.02,偏瘦组14.8%、肥胖组10.7%。
- 手术部位感染差异P=.05,偏瘦患者3.7%。
- 需再手术的部分移植物失败在较低BMI组更常见,P=.04。
- 功能结局:触觉≥98%、外观满意度>97%、插入式性交能力20%-40%,组间P>.05。
临床怎么用
- 术前可按BMI分层评估围手术期并发症风险,重点关注意外失血、尿路感染与手术部位感染。
- 偏瘦患者需警惕手术部位感染和移植物失败再手术风险。
- 肥胖患者需关注估计失血量增加;BMI本身不应作为手术排除标准。
局限性
- 单中心回顾性设计,结果外推需谨慎。
- 原文未报告各组样本量、具体P值(除已列出的以外)及置信区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To diversify the understanding of body mass index's (BMI) influence on vaginoplasty outcomes. As previous studies have assessed the role of increased BMI on gender-affirming vaginoplasty outcomes, no studies are currently published on the risks associated with an underweight BMI, nor do current studies present with statistical power due to limited sample sizes. This analysis represents the first and largest bidirectional assessment of BMI on vaginoplasty post-operative and functional outcomes. METHODS: A retrospective cohort study was conducted of 766 patients undergoing primary vaginoplasty between 2016 and 2023 at a single institution. The primary exposure was body mass index (BMI): underweight (<18.5 kg/m²), normal (18.5-24.9 kg/m²), overweight (25-29.9 kg/m²), and obese (≥30 kg/m²). Continuous variables were analyzed using Kruskal-Wallis tests, and categorical outcomes using Chi-square or Fisher's exact tests, with P<.05 considered significant. The final dataset was analyzed using R version 4.5.1. RESULTS: Obese patients had significantly greater estimated blood loss (P<.05). Postoperative urinary tract infection (UTI) rates differed by BMI (P=.02, highest among underweight (14.8%) and obese (10.7%) groups. Surgical site infection (SSI) also varied by BMI (P=.05), occurring primarily in underweight patients (3.7%). Partial graft failure requiring reoperation was more frequent among lower-BMI cohorts (P=.04). All other complications did not differ significantly across groups. Functional outcomes were uniformly favorable, with tactile sensation (≥98%), cosmetic satisfaction (>97%), and penetrative intercourse ability (20%-40%) consistent across BMI categories (P>.05). CONCLUSION: Ultimately, BMI influences perioperative morbidity but should not preclude patients from gender-affirming vaginoplasty.
引用
- Callahan DM, Hinderscheid C, Ramsay A, et al. Impact of Body Mass Index on Surgical Outcomes in Gender-Affirming Vaginoplasty: A Retrospective Cohort Analysis. Urology. 2026. PMID: 42692269. doi:10.1016/j.urology.2026.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。